Finance

Lists
524715:BOM
Sun Pharmaceutical Industries Ltd
၁,၇၆၀.၀၀ ₹
-၀.၀၃%
(-၀.၆၀) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524715...
Open
၁,၇၅၉.၆၀ ₹
High
၁,၇၆၄.၄၀ ₹
Low
၁,၇၄၄.၈၅ ₹
Mkt. cap
ဋေ ၄.၂၂ သိန်း
Avg. vol.
၉.၇၄ သောင်း
Volume
၃.၅၇ သောင်း
Dividend
၀.၉၁%
Quarterly dividend
၄.၀၀ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၇
P/E ratio
၃၄.၈၉
52-wk high
၂,၀၄၇.၅၅ ₹
52-wk low
၁,၅၈၃.၆၀ ₹
EPS
၅၀.၄၄ ₹
Shares outstanding
၀.၀၀
No. of employees
၅ သောင်း
Open
၁,၇၅၉.၆၀ ₹
High
၁,၇၆၄.၄၀ ₹
Low
၁,၇၄၄.၈၅ ₹
Mkt. cap
ဋေ ၄.၂၂ သိန်း
Avg. vol.
၉.၇၄ သောင်း
Volume
၃.၅၇ သောင်း
Dividend
၀.၉၁%
Quarterly dividend
၄.၀၀ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၇
P/E ratio
၃၄.၈၉
52-wk high
၂,၀၄၇.၅၅ ₹
52-wk low
၁,၅၈၃.၆၀ ₹
EPS
၅၀.၄၄ ₹
Shares outstanding
၀.၀၀
No. of employees
၅ သောင်း
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၂ ရက်
Sun Pharma stock: Results are due October 29 for Sun Pharma stock
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၃ ရက်
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd
CEO-
Employees၄.၇ သောင်း
Founded၁၉၈၃
HeadquartersGoregaon East, မွမ်ဘိုင်းမြို့, အိန္ဒိယ
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၄၅ သ
ဋေ ၁.၅၅ သ
ဋေ ၁.၄၆ သ
ဋေ ၁.၅၃ သ
Cost of goods sold
ဋေ ၂.၉၈ ထ
ဋေ ၂.၉၅ ထ
ဋေ ၃.၇၄ ထ
ဋေ ၂.၉၆ ထ
Cost of revenue
ဋေ ၂.၉၈ ထ
ဋေ ၂.၉၅ ထ
ဋေ ၃.၇၄ ထ
ဋေ ၂.၉၆ ထ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၂.၇၆ ထ
ဋေ ၂.၈၉ ထ
ဋေ ၃.၀၆ ထ
ဋေ ၃.၂၃ ထ
Operating expense
ဋေ ၈.၁၃ ထ
ဋေ ၈.၅၁ ထ
ဋေ ၈.၀၇ ထ
ဋေ ၈.၇၈ ထ
Total operating expenses
ဋေ ၁.၁၁ သ
ဋေ ၁.၁၅ သ
ဋေ ၁.၁၈ သ
ဋေ ၁.၁၇ သ
Operating income
ဋေ ၃.၃၇ ထ
ဋေ ၄.၀၆ ထ
ဋေ ၂.၈၁ ထ
ဋေ ၃.၅၆ ထ
Other non operating income
၄၆၉.၉၂ ဋေ
၅၇၈.၈၄ ဋေ
-ဋေ ၁.၄၃ ထ
၇၂၃.၆၂ ဋေ
EBT including unusual items
ဋေ ၄.၁၆ ထ
ဋေ ၄.၂၁ ထ
ဋေ ၃.၅၄ ထ
ဋေ ၄.၀၉ ထ
EBT excluding unusual items
ဋေ ၄.၁၆ ထ
ဋေ ၄.၇၀ ထ
ဋေ ၂.၆၈ ထ
ဋေ ၄.၂၉ ထ
Income tax expense
ဋေ ၁.၀၃ ထ
၈၂၆.၀၇ ဋေ
၈၂၇.၆၂ ဋေ
ဋေ ၁.၁၉ ထ
Effective tax rate
၂၄.၈၀%
၁၉.၆၃%
၂၃.၄၀%
၂၉.၀၅%
Other operating expenses
ဋေ ၄.၆၃ ထ
ဋေ ၄.၈၉ ထ
ဋေ ၄.၂၃ ထ
ဋေ ၄.၈၁ ထ
Net income
ဋေ ၃.၁၂ ထ
ဋေ ၃.၃၇ ထ
ဋေ ၂.၇၁ ထ
ဋေ ၂.၈၉ ထ
Net profit margin
၂၁.၅၄%
၂၁.၇၁%
၁၈.၅၇%
၁၈.၉၂%
Earnings per share
၁၃.၀၀
၁၅.၄၈
၁၁.၃၀
၁၂.၇၁
Interest and investment income
-
-
၉၇၄.၄၀ ဋေ
-
Interest expense
-၉၉.၈၆ ကုဋေ
-၇၈.၃၆ ကုဋေ
-၈၅.၈၉ ကုဋေ
-၉၉.၆၇ ကုဋေ
Net interest expenses
-၉၉.၈၆ ကုဋေ
-၇၈.၃၆ ကုဋေ
၈၈၈.၅၁ ဋေ
-၉၉.၆၇ ကုဋေ
Depreciation and amortization charges
၇၂၉.၅၀ ဋေ
၇၃၂.၃၃ ဋေ
၇၇၅.၄၇ ဋေ
၇၃၈.၇၂ ဋေ
EBITDA
ဋေ ၄.၀၈ ထ
ဋေ ၄.၆၅ ထ
ဋေ ၃.၄၉ ထ
ဋေ ၄.၂၃ ထ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ